Access decisions are made by a small, defined set of people – and understanding how they think requires more than periodic surveys or publicly available policy documents.

Spherix’s Market Access practice combines continuous structured primary research with formulary decision-makers and the strategic depth of a team that has spent decades inside the access conversation. What that delivers in practice: benefit design tracking across commercial and government payers, account team performance benchmarking, current detailed profiles of the plans and systems controlling formulary placement in your category, and the analytical context to translate all of it into access strategy.

Every output goes beyond the data. Spherix Market Access specialists review, interpret, and pressure-test every finding before delivery, with AI compressing the time it takes to synthesize years of account history into a clear view of what has changed – so what reaches your team is a commercial answer, not a dataset to decode.